Punjab has developed the vaccine to help prevent breast cancer among women, reported by the Institute of Public Health. The development of the Human Papillomavirus (HPV) vaccine has sparked a policy discussion that experts believe could mark a significant turning point in the nation’s healthcare system.

Punjab Finance Minister Mujtaba-Shuja-Ur Rehman praised the breakthrough, stating that the Institute of Public Health s creation of the Papilloma vaccine is a remarkable achievement. He added that the provincial government is placing special emphasis on the health sector.

Also Read: Lahore hospital sets record with 100 Robotic surgeries

Professor Dr. Javed Akram, a renowned medical specialist, said that the vaccine would aid in the prevention of breast cancer. He explained that women could be protected against the disease for life if they receive three doses of the vaccine at the age of twelve.

The U.S Food and Drug Administration (FDA) recently approved a new breast cancer treatment called Datroway, which was developed by AstraZeneca in partnership with the Japanese company Daiichi Sankyo.

This medicine is intended for patients with advanced breast cancer who have already undergone other treatments. It s a precision drug, meaning it’s designed to target cancer cells specifically, rather than affecting all cells like traditional chemotherapy.

Datroway is part of a class of drugs known as antibody-drug conjugates (ADCs). These are often called "guided missiles" because they combine an antibody (which targets cancer cells) with a drug (which kills them). This approach helps kill cancer cells while minimizing damage to healthy cells, which can reduce side effects.

The cost of Datroway is $4,891.07 per vial, and it will be available in the U.S by prescription within about two weeks.